In today’s medical device landscape, real-world evidence (RWE) is more than a buzzword — it’s a strategic differentiator. Whether you’re enhancing market access, informing risk management decisions, or strengthening regulatory submissions, RWE empowers teams with insight grounded in actual device performance and user experience.
However, capturing RWE is easier said than done. Many manufacturers struggle with fragmented data, inconsistent methodologies, and uncertainty over data integrity — especially when using general-purpose survey tools not designed for regulated environments.
That’s where 1Survey+ delivers a unique advantage.
Why Real-World Evidence Matters for MedTech
Real-world evidence helps manufacturers answer the questions that matter most:
- How is the device performing outside controlled trials?
- What outcomes are patients and clinicians seeing in real settings?
- Are there trends in usability, training gaps, or safety signals?
- How can we improve future versions of our products?
When RWE is collected in a structured, compliant way, it becomes not just data — but decision-ready insight.
The Limitations of Traditional Feedback Methods
Generic survey tools can collect responses, but that’s where their usefulness often ends:
- Lack of audit trail or traceability
- No compliance with regulated data standards
- Manual curation and reporting required
- Limited scalability across geographies and languages
These gaps can undermine confidence in your evidence — exactly when you need it most.
1Survey+: Designed for Real Evidence in the Real World
1Survey+ is purpose-built to support RWE programs that are compliant, traceable, and scalable. With features tailored to regulated industries, 1Survey+ ensures the evidence you collect is: ✔ Methodologically sound ✔ Regulator-ready ✔ Easily distributed and monitored ✔ Richly documented for submission or strategic use
Whether you’re gathering outcomes from clinicians, experiences from patients, or insights from field teams, 1Survey+ makes the process seamless.
From Data Collection to Decisions
With 1Survey+, teams can:
- Visualize trends via dashboards
- Generate reports for internal stakeholders or regulators
- Track quality signals that inform product improvement
- Scale RWE programs across regions and populations
Real-world evidence should empower action — not uncertainty.
Conclusion: In a rapidly evolving MedTech environment, RWE isn’t a “nice-to-have” — it’s essential. With 1Survey+, you turn everyday data into evidence you can trust, use, and act on with confidence.
Book a live demo to explore how 1Survey+ strengthens your RWE strategy demo@1med.net
